Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.690
+0.150 (9.74%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pyxis Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 100 | 80 | 47 | 353 | - | - |
| Market Cap Growth | 150.00% | 70.77% | -86.78% | - | - | - |
| Enterprise Value | -24 | -32 | -136 | 414 | - | - |
| Last Close Price | 1.69 | 1.80 | 1.34 | 10.97 | - | - |
| PB Ratio | 0.65 | 0.63 | 0.29 | 1.35 | - | - |
| P/TBV Ratio | 1.68 | 0.79 | 0.29 | 1.35 | - | - |
| Debt / Equity Ratio | 0.13 | 0.17 | 0.12 | 0.00 | 0.12 | 0.00 |
| Quick Ratio | 7.13 | 4.63 | 5.69 | 14.69 | 2.19 | 26.86 |
| Current Ratio | 7.33 | 4.84 | 5.90 | 14.90 | 2.20 | 26.88 |
| Return on Equity (ROE) | -39.34% | -51.51% | -57.19% | -56.78% | -101.15% | - |
| Return on Assets (ROA) | -21.06% | -26.10% | -31.41% | -30.03% | -53.80% | - |
| Return on Capital (ROIC) | -24.11% | -30.76% | -34.98% | -32.45% | -61.61% | - |
| Earnings Yield | -57.07% | -92.53% | -258.49% | -21.50% | - | - |
| FCF Yield | -53.61% | -97.10% | -205.00% | -10.15% | - | - |
| Buyback Yield / Dilution | -44.74% | -20.80% | -288.93% | -724.14% | -53.40% | - |
| Total Shareholder Return | -44.74% | -20.80% | -288.93% | -724.14% | -53.40% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.